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1. Introduction 
The receptor (ACh.R) for acetylcholine (ACh) has 
so far been obtained in apparently pure form only 
from fish electric organs (for reviews, see [ 1,2] ). 
From vertebrate skeletal muscle, on the other hand, 
where ACh.R is essential for synaptic transmission 
and for denervation supersensitivity to ACh, no exten- 
sive purification has been reported. Muscle is a much 
poorer source of ACh.R, and even after its prolifera- 
tion following denervation it is far below the level in 
the electric organ of Torpedo. For muscles, quantita- 
tion and localisation of ACh.R, by exploitation of its 
essentially irreversible binding of labelled cu-bungaro- 
toxin (BuTX), was initially described [3], and solubili- 
sation of this ACh.R in detergents and some fractiona- 
tion has been reported [4-71. Subsequently [S] , we 
reported upon a preparation, partly purified by affinity 
chromatography, of the form of ACh.R which is 
responsible for the extrajunctional ACh sensitivity of 
denervated mammalian muscle. We have further 
applied affinity chromatography in a more bio-specific 
form (in the sense in which this technique has been 
critically reviewed by Barry and O’Carra [9] ), and 
describe here the complete purification of this muscle 
ACh.R. 
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2. Materials and methods 
2.1. Receptor assay and analytical methods 
BuTX and [3 H] -acetylated-BuTX ( [3 H] BuTX), 
and the assay method for ACh.R based upon its rapid, 
saturable binding of [3H]BuTX, were all as described 
previously [S] , as were materials not separately 
specified here. Protein was determined on 100 ~1 
aliquots by Folin reaction [lo] , adapted where 
necessary for high sensitivity by reduction of the 
final volume of the reaction mixture to 0.2-0.4 ml 
and the use of micro cells; bovine serum albumin 
(Sigma) was used as the standard. Acetylcholinesterase 
(AChE) was determined by acetylthiocholine reaction 
[ 111, similarly adapted. 
2.2. Extraction of the ACh.R 
Chronically denervated cat leg muscles [S] were 
used as previously [S] : these are the mixed muscles 
in the lower hind leg supplied by all branches of the 
sciatic nerve, which was transected in the thigh about 
4 weeks prior to sacrifice. The muscles were cut up 
finely and extracted (1 g per 2 ml medium) in 1.5% 
Triton X-100/50 mM K phosphate, pH 8, shaking in a 
bath at 5°C. Phenylmethanesulfonyl fluoride ( 10V4 M), 
benzethonium chloride (1 0m4 M) and EDTA (10-j M) 
(all from Sigma) were present as protease inhibitors. 
The supernatant after centrifugation at 75 OOOg, 20 
min, was used without storage. All subsequent opera- 
tions were at S’C. 
2.3. Affinity chromatography 
Sepharose 4B was coupled, via two lengths of the 
arm NH(CHz)3NH(CH2)aNHCO(CH2)2 CO-, to tri- 
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Fig.1. Affinity chromatography of receptor. The affinity 
column was equilibrated in 0.05 M K phosphate/0.2% Triton 
X-l 00, and washed after sample loading (A) with 0.05 M 
NaCl in that medium (60 ml). The receptor activity (0) and 
protein content (m), when read in the breakthrough volume 
(broken lines) and the washes (up to B), are expressed as 
though concentrated to 1 ml fractions from the larger volumes 
used. At B, 2.1 mM Flaxedil in the same NaCl medium was 
applied, and 1 ml fractions were collected. The first half of 
the peak was pooled for further purification. Note that the 
scale for protein is expanded lOOO-fold after the Flaxedil 
elution commences. 
methyl (p-aminophenyl) ammonium chloride by the 
method of Berman and Young [12]. A column (6 ml) 
was equilibrated in 50 mM K phosphate, pH 810.2% 
Triton X-100. The sample was applied and washed in 
the same medium, and eluted as shown in fig. 1, using 
Flaxedil (May and Baker). When Flacedil and NaCl 
eluents were applied, these solutes were largely remov- 
ed from the effluent by passing it (at 10 ml/hr) 
through hollow fibres of two Minibeaker dialyzers 
(BioRad Labs.) in series, outside which was pumped 
0.2% Triton X-100 at 80 ml/mm. Further details of 
the purification methods will be given in a full account 
elsewhere. 
2.4. Gel electrophoresis 
A system based on that specified by Hyden and 
Langer [ 131 was used, but employing 5% polyacryla- 
mide in the running gel (0.5 X 9 cm) at pH 9, and 
2.5% in the stacking el at pH 7.5.0.1% Triton X-100 
was in all media; 4 mA/tube was applied. 
3. Results 
3.1. Isolation of AC%. R from muscle 
Cat denervated lower leg muscles were extracted in 
1.5% Triton X-l 00, until solubilization had occurred 
(usually overnight) of at least 80% of the total receptor 
content of the muscle. 
The ACh.R solution was fractionated on a column 
either of Sepharose 6B or of Ultragel AcA 22, in 0.2% 
Triton X-100/10 mM phosphate (pH 8) to yield a 
single peak of receptor activity, centred in the zone 
corresponding to apparent molecular weights of 
400 000-500 000 (as illustrated previously [7]). 
Most of the protein present emerged after this peak. 
About the first two-thirds of this ACbR peak was 
pooled, concentrated by ultrafiltration on a Millipore 
PSJM membrane, and at once applied to the affinity 
column. 
As shown in frg.1, the great bulk of the protein 
present was removed in the non-absorbed orsalt-elut- 
ed fractions from this column, but essentially all the 
receptor was retained (unless the column was overload- 
ed). When no more protein could be removed by the 
salt wash given, 2.1 mM Flaxedil (gallamine triethiodide) 
solution was used to achieve abio-specific [9] elution 
of ACh.R. This eluent also displaced asmall amount 
of other protein. The use of NaCl gradients, or of d- 
tubocurarine (&TC) or carbachol as alternative ligands, 
even at much higher concentrations gave poor purifica- 
tions or yields. Almost all the Flaxedil was removed 
by continuous flow dialysis, and correction was made 
for the effect of residual ligand in the assays after 
performing the latter at several dilutions of the effluent 
sample. 
Final separation from extraneous protem was made 
by ion-exchange chromatography on DEAE-Sephadex 
(Whatman, A-25). Details are shown in tig.2. It is seen 
that a gradient of NaCl separates the ACh.R from the 
residual protein, which either is not bound to this 
ion-exchanger (broken line in fig.2 profile) or is only 
slightly retarded (first protein peak), or is displaced at 
a higher NaCl concentration than elutes the ACh.R. 
Pure ACh.R was taken from the central fractions of 
the peak of activity. 
Troughout, we take 1 nmol of ACh.R as that 
amount which binds 1 nmol of [“HI BuTX when the 
plateau of specific uptake in the assay IS] is reached. 
In the crude extract, each gram of denervated muscle 
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Fig.2. Ion-exchange chromatography of receptor. A column 
(0.7 x 2 cm) of DEAE-Sephadex was equilibrated in 25 mM 
K phosphate (pH 8)/O.l% Triton X-100, and was washed after 
sample loading (A) with 0.1 M NaCl in that medium (35 mi). 
Notation up to point B is as given for tig.1. At B, a linear 
gradient in the same medium, from 0.1 to 1.2 M NaCl(l0 ml 
of each) was applied, with continuous flow dialysis of the 
effluent (as for the affinity column) against 0.1% Triton X-100, 
and 1 ml fractions were collected. Fractions 16- 18 were 
taken to give the final product. 
gave rise to about 80 pmol of ACh.R. Recovery in the 
entire peak of ACh.R on the gel filtration column was 
about 100% but, as noted, about one-third of this 
was discarded. Recovery in the peak in bio-specific 
chromatography was 62% of the applied receptor. 
Ignoring all overlap fractions that were discarded at 
the three chromatographic steps, the final recovery 
of the pure component was 14% of the ACh.R in the 
original crude extract. The overall purification typical- 
ly achieved with respect to the crude extract is 3800- 
fold. 
3.2. Criteria for the purity of the ACh. R 
The first criterion to be considered is specific 
activity. The final product had in the usual case a 
value of 3 500 nmol/g protein, and in the best case so 
far realized 6000 nmol/g. The protein content was 
found using an adaptation of the Folin-Lowry method, 
based upon the arbitrary use of serum albumin as a 
standard. It has been reported that the pure electro- 
plaque receptor shows values in this same range for 
its specific activity (reviewed in Refs. [ 1,2] ), but that 
they increase by about 33% when the protein estima- 
tion is made, more correctly, by amino acid analysis 
Fig.3. Gel electrophoresis of the final ACh.R product (r), 
stained with Amido-Schwartz. Origin at top; s=human serum 
albumin (pZ = 4.9) as reference, run for one-half the period 
used for the ACh.R tube. In shorter runs of ACh.R, where the 
tracking dye had not migrated to the end, it was checked that 
no faster components were detectable. In absorbance scanning 
the band appeared homogeneous. 
[ 141. The muscle ACh.R has a specific activity, there- 
fore, in the same range as the purest preparations report- 
ed of the electroplaque ACh.R! being 8000 nmoles/g 
if thus corrected, in the purest sample obtained. 
Secondly, gel electrophoresis (in non-denaturing 
medium) was applied for detection of impurities. In 
the final product only a single band of protein was 
was detectable (fig.3). Running of the gels for shorter 
and for longer periods, to look for components run- 
ning off rapidly or barely separated from the main 
component, did not yield any other bands. 
Thirdly, ACh.E was undetectable in the pure ACh.R. 
The ACh.R fractions, even at the early stage of the 
peak of activity on the first gel column used, contain- 
ed no ACbE activity except at the lower trailing edge 
of the ACh.R peak on that column, a region which was 
discarded, so that ACh.E was found to be totally ab- 
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sent later. On the basis that the muscle ACh.E has 
the specific activity of pure electroplaque ACh.E [ 151, 
the limits of assay showed that the final ACh.R pro- 
duct contained less than 0.0004% of active ACh.E. 
3.3. Properties of the pure ACh.R 
The pure ACh.R was stable for several weeks at 
4’C (in the presence of 0.01% Na azide), losing only a 
few per cent of its activity then. This is in contrast to 
the considerable instability of the muscle ACh.R at 
early stages of the isolation. The material upon 
complete hydrolysis in 6N HCl and analysis gave a 
typical amino acid content, which will be reported 
elsewhere, confirming its protein identity. 
The molecular weight as estimated by gel filtration 
[7] (on Sepharose 6B in 0.2% Triton X-100) is 430 000. 
This is only on the basis of Stokes’ radius comparisons, 
with globular proteins as standards. It has been shown 
that a similar value is obtained for electroplaque ACh.R 
in such gel filtration conditions and this is an over- 
estimate of the molecular weight, due to the binding 
of detergent, the true value being derived by other 
methods being about 250 000 [ 161. Further analysis 
of the molecular weight of the muscle ACh.R will be 
reported elsewhere, but it is clear that the size of this 
protein is similar to that of electroplaque ACh.R. 
Specific binding of cholinergic ligands to the ACh.R 
was demonstrated by their ability to retard the reac- 
tion with the toxin. The initial rates of [3 H] Butx 
reaction at 25’C in the presence of various concentra- 
tions of a given ligand, above and below its estimated 
affinity constant (K,) for the ACh.R, were used for 
this purpose, as described previously [8] for less pure 
muscle ACh.R. In the presence of saturating concentra- 
tions of d-tubocurarine (d-TC) ( 10e4 M) or of ACh 
(10m3M) the reaction with [3H] BuTX (2 - 4 nM) was 
suppressed, the initial rate (over 30 min) being 6% 
(d-TC) or 0% (ACh) of the normal initial rate. This is 
to be compared with the 10-l 5% of the toxin-binding 
sites that were found incapable of binding these ligands 
in less pure and less protected preparations [8]. 
Values of K, for the pure ACh.R with various 
ligands, determined by the protection method, will be 
reported elsewhere [ 171. They are quite similar to 
those reported for the pure electroplaque ACh.R [ 1,2] , 
with high affinity (KD < lo-‘M) sites for ACh, and 
strong binding of (I-TC, carbamylcholine and deca- 
methonium. 
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4. Discussion 
ACh.R from denervated mammalian muscle can be 
solubilized in dilute solutions of Triton X- 100 or other 
detergents [7] and can be completely purified by a 
combination of gel filtration, biospecitic chromate. 
graphy and ion-exchange chromatography. The final 
product is a homogeneous protein. It has a specific re- 
ceptor activity similar to that of the pure ACh.R from 
electroplaques. 
The properties of the protein finally obtained that 
categorized it as an ACh receptor include the rapidity 
and specificity of the reaction with BuTX, and the high 
affinities for a typical spectrum of nicotinic choliner- 
gic ligands. It has already been shown [8] on this 
ACh.R in less pure form that non-nicotinic ligands 
(e.g. atropine, pilocarpine, choline) exhibit only low 
affinities for this component, whereas the K, values 
for nicotinic ligands there are in a series consistent 
with their pharmacological effectiveness. 
The receptor purified here is that from denervated 
muscle. The endplate ACh.R of innervated muscle may 
not be identical. A small difference in iso-ionic points 
between soluble forms of these two types has been 
reported [ 181; differences in blocking by d-TC in 
intact muscle in the two states have been analyzed 
[19], but these are not major. Others have found [20] 
no difference between ACh.R in homogenates of 
normal and of denervated muscle in their correspon- 
ding affinities for a series of nicotinic agonists and 
antagonits. The known physiological differences 
between normal and denervated muscle could, alter- 
natively, arise from a difference in the associated ion 
translocation modulator in the two cases. However, 
isolation of the endplate ACh.R, although this is much 
less abundant, would be feasible by the method used 
here, and a comparison will be presented elsewhere. 
The information so far obtained on the muscle 
ACh.R is sufficient to indicate a close relationship to 
that from electroplaques of various sources, beyond 
the level [ 1,2] at which the latter may differ between 
species. The o-neurotoxin reactivity, detergent 
solubility, nicotinic ligand binding, and molecular 
weight are essentially similar in each case. It appears, 
from the specific activities obtained, that an ACh-bin- 
ding unit of the order of 100 000-l 50 000 daltons 
per o-toxin-binding site is the common basis of the 
nicotinic ACh.R from these diverse sources. 
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